Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting Database
BÉGAUD, Bernard
Pharmacoepidemiologie et évaluation de l'impact des produits de santé sur les populations
< Réduire
Pharmacoepidemiologie et évaluation de l'impact des produits de santé sur les populations
Langue
en
Article de revue
Ce document a été publié dans
Drug Safety. 2017-11, vol. 40, n° 11, p. 1099-1107
Springer Verlag
Résumé en anglais
The objective of this study was to analyse the changes in the reporting of adverse events (AEs) for therapeutic alternatives after the withdrawal of three medicines (dextropropoxyphene, pioglitazone and tetrazepam) from ...Lire la suite >
The objective of this study was to analyse the changes in the reporting of adverse events (AEs) for therapeutic alternatives after the withdrawal of three medicines (dextropropoxyphene, pioglitazone and tetrazepam) from the market for safety reasons.< Réduire
Mots clés en anglais
medicine
therapeutic alternatives
politics
Project ANR
Initiative d'excellence de l'Université de Bordeaux - ANR-10-IDEX-0003
Origine
Importé de hal